BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Prognosis
23 results:

  • 1. Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic liver Classification B) Receiving Systemic Therapy.
    Ielasi L; Stefanini B; Conti F; Tonnini M; Tortora R; Magini G; Sacco R; Pressiani T; Trevisani F; Foschi FG; Piscaglia F; Granito A; Tovoli F
    Curr Oncol; 2024 Jan; 31(1):547-557. PubMed ID: 38275831
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic and survival impact of bcl9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma.
    Youssef SS; El-Araby RE; Abbas EAE; Hassany M; Elbaz T
    Expert Rev Mol Diagn; 2023 Mar; 23(3):267-278. PubMed ID: 36803362
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Poly-hydroxylated bile acids and their prognostic roles in Alagille syndrome.
    Wang MX; Han J; Liu T; Wang RX; Li LT; Li ZD; Yang JC; Liu LL; Lu Y; Xie XB; Gong JY; Li SY; Zhang L; Ling V; Wang JS
    World J Pediatr; 2023 Jul; 19(7):652-662. PubMed ID: 36658452
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohort.
    Kozuka R; Tamori A; Enomoto M; Muto-Yukawa Y; Odagiri N; Kotani K; Motoyama H; Kawamura E; Hagihara A; Fujii H; Uchida-Kobayashi S; Kawada N
    J Viral Hepat; 2023 May; 30(5):374-385. PubMed ID: 36583600
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cuproptosis-Related LncRNA Signature for Predicting prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis.
    Chen Q; Sun T; Wang G; Zhang M; Zhu Y; Shi X; Ding Z
    Dis Markers; 2022; 2022():3265212. PubMed ID: 36452343
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
    Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
    Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Simultaneous versus staged major hepatectomy (≥3 liver segments) for outcomes of synchronous colorectal liver metastases: A systematic review and meta-analysis.
    Liu J; Xia Y; Pan X; Yan Z; Zhang L; Yang Z; Wu Y; Xue H; Bai S; Shen F; Wang K
    Cancer Rep (Hoboken); 2022 Aug; 5(8):e1617. PubMed ID: 35753719
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection.
    Zhang L; Hu J; Hou J; Jiang X; Guo L; Tian L
    Abdom Radiol (NY); 2021 Aug; 46(8):3845-3854. PubMed ID: 33733337
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry.
    Kim JM; Kim DG; Kim J; Lee K; Lee KW; Ryu JH; Kim BW; Choi DL; You YK; Kim DS; Nah YW; Kang KJ; Cho JY; Hong G; Yu HC; Moon JI; Choi D; Hwang S; Kim MS
    Clin Mol Hepatol; 2021 Jul; 27(3):451-462. PubMed ID: 33525077
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy.
    Liu JM; Wang YY; Liu W; Xu D; Wang K; Xing BC
    Int J Colorectal Dis; 2021 Apr; 36(4):767-778. PubMed ID: 33420522
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of lymph node evaluation and yield among patients undergoing open and minimally invasive surgery for gallbladder adenocarcinoma.
    Hamad A; Cloyd JM; Dillhoff M; Manilchuk A; Pawlik TM; Tsung A; Ejaz A
    Surg Endosc; 2021 May; 35(5):2223-2228. PubMed ID: 32430521
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting bcl9.
    Yao B; Li Y; Wang L; Chen T; Niu Y; Liu Q; Liu Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3885-3895. PubMed ID: 31561723
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma.
    Han Q; Wang X; Liao X; Han C; Yu T; Yang C; Li G; Han B; Huang K; Zhu G; Liu Z; Zhou X; Su H; Shang L; Gong Y; Song X; Peng T; Ye X
    Oncol Rep; 2019 Sep; 42(3):895-910. PubMed ID: 31322232
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.
    Xu L; Li L; Wang P; Zhang M; Zhang Y; Hao X; Yan L; Li B; Wen T; Xu M
    Gut Liver; 2019 Nov; 13(6):669-682. PubMed ID: 30970430
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
    Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
    Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting bcl9.
    Yang C; Xu Y; Cheng F; Hu Y; Yang S; Rao J; Wang X
    Cell Death Dis; 2017 Aug; 8(8):e2999. PubMed ID: 28817119
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathological factors and gastric cancer prognosis in the iranian population: a meta-analysis.
    Somi MH; Ghojazadeh M; Bagheri M; Tahamtani T
    Asian Pac J Cancer Prev; 2015; 16(3):853-7. PubMed ID: 25735372
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study.
    Zeng QA; Qiu J; Zou R; Li Y; Li S; Li B; Huang P; Hong J; Zheng Y; Lao X; Yuan Y
    BMC Cancer; 2012 Apr; 12():148. PubMed ID: 22510321
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.
    Okamoto K; Ishida C; Ikebuchi Y; Mandai M; Mimura K; Murawaki Y; Yuasa I
    Intern Med; 2010; 49(10):887-95. PubMed ID: 20467172
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.